TipRanks
Tevogen Bio Holdings (DE:G280)
FRANKFURT:G280
Germany Market
G280
Tevogen Bio Holdings
RESEARCH TOOLSreports

Tevogen Bio Holdings (G280) Cash flow

2 Followers

Tevogen Bio Holdings Cash Flow

DE:G280's free cash flow for Q2 2026 was $-3.01M. For the 2026 fiscal year, DE:G280's free cash flow was decreased by $-394.29K and operating cash flow was $-3.01M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Mar 25Mar 24Dec 22Dec 21
Operating Cash Flow
$ -12.33M$ -12.00M$ -8.17M$ -8.66M$ -5.27M
Investing Cash Flow
$ -64.44K$ 0.00$ -133.00K$ -479.04K$ -109.73K
Financing Cash Flow
$ 11.66M$ 12.23M$ 3.87M$ 7.50M$ 12.50M
End Cash Position
$ 552.37K$ 1.28M$ 1.05M$ 5.48M$ 7.12M
Free Cash Flow
$ -12.39M$ -12.00M$ -8.30M$ -9.13M$ -5.38M
Currency in USD

Tevogen Bio Holdings Cash Flow